Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine Oct. 5, 2020 Filed Under: Pharma Tagged With: heart disease, Keio University, medicine, R&D, regenerative medicine, researchHeartseed Inc., a venture company out of Keio University, has its eyes set on bringing about a new cardiovascular regenerative…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Gunze Targets Regenerative Medicine Market With…Sumitomo Dainippon Pharma to Expand Regenerative and…Sumitomo Riko Looks to Deploy Smart Rubber as Monitoring…Gunze Looks Global With Development of Bioabsorbable…Mitsubishi Chemical to Produce Regenerative Medicine…LSII to Launch Clinical Trials of Muse Cells to Treat…